In Brief: CNS, Inc.
This article was originally published in The Tan Sheet
Executive Summary
CNS, Inc.: Gains FDA clearance to market its Breathe Right nasal strip "for the reduction or elimination of snoring," the company announces Nov.8. The clearance allows the company to expand its present claim for the product, cleared in 1993, that it "improves nasal breathing by reducing nasal airway resistance." CNS says that recent studies have shown that "75% of participants snored less often and less loudly when wearing the Breathe Right strip." The Minneapolis-based firm estimates that there are 40 mil. chronic snorers in the U.S...